Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multinational Multicenter, Randomized , Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ad5FGF-4 in Patients With Stable Angina

NCT00185263 is registered in ClinicalTrials.gov with Cardium Therapeutics as lead sponsor.

NCT NCT00185263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00185263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multinational Multicenter, Randomized , Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ad5FGF-4 in Patients With Stable Angina
Lead sponsor
Cardium Therapeutics
Phase
Phase 2/3
Overall status
Unknown status
Start date
March 31, 2002
Completion date
November 30, 2008
Enrollment
116 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

stable angina